An Antigenic Threshold for Maintaining Human Immunodeficiency Virus Type 1-specific Cytotoxic T Lymphocytes

Molecular Medicine

Volumn 6, Issue 9, 2000, Pages 803-809

  Jin, Xia ^a   Ogg, Graham ^b   Bonhoeffer, Sabstian ^c   Safrit, Jeffrey ^d   Vesanen, Mika ^a   Bauer, Daniel ^a   Chen, Donald ^a   Cao, Yunzhen ^a,e   Demoitie, Marie Ange ^a   Zhang, Linqi ^a   Markowitz, Martin ^a   Nixon, Douglas ^a   McMichael, Andrew ^b   Ho, David D ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Antigen Threshold; CTL Effector (CTLe); CTL Precursors (CTLp); Long term Nonprogressors (LTNPs); Viremia Levels

Indexed keywords

CD8 ANTIGEN; EPITOPE; GAG PROTEIN;

ADULT; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS LOAD;

ADULT; ANTIGENS, CD8; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; EPITOPES; FEMALE; GENE PRODUCTS, GAG; GENES, MHC CLASS I; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROVIRUSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VIRAL LOAD; VIREMIA;

MLCS; MLOWN;

EID: 0034279805     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03402195     Document Type: Article

References (22)

1. C.A. Michie A. McLean C. Alcock P.C. Beverley Lifespan of human lymphocyte subsets defined by CD45 isoforms Nature 1992 360 264 265 1:STN:280:DyaK3s%2Fmtlelug%3D%3D 10.1038/360264a0
2. H. Mohri S. Bonhoeffer S. Monard A.S. Perelson D.D. Ho Rapid turnover of T lymphocytes in SIV-infected rhesus macaques Science 1998 279 1223 1227 1:CAS:528:DyaK1cXhtlShsLo%3D 10.1126/science.279.5354.1223
3. B.D. Jamieson R. Ahmed T cell memory. Long-term persistence of virus-specific cytotoxic T cells J. Exp. Med. 1989 169 1993 2005 1:STN:280:DyaL1M3nvFWnug%3D%3D 10.1084/jem.169.6.1993
4. Y. Ke H. Ma J.A. Kapp Antigen is required for the activation of effector activities, whereas interleukin 2 is required for the maintenance of memory in ovalbumin-specific, CD8+ cytotoxic T lymphocytes J. Exp. Med. 1998 187 49 57 1:CAS:528:DyaK1cXjtV2ntg%3D%3D 10.1084/jem.187.1.49
5. L.L. Lau B.D. Jamieson T. Somasundaram R. Ahmed Cytotoxic T-cell memory without antigen Nature 1994 369 648 652 1:CAS:528:DyaK2cXksFGntb8%3D 10.1038/369648a0
6. S. Oehen H. Waldner T.M. Kundig H. Hengartner R.M. Zinkernagel Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen J. Exp. Med. 1992 176 1273 1281 1:CAS:528:DyaK38XlvV2ku7s%3D 10.1084/jem.176.5.1273
7. G.S. Ogg X. Jin S. Bonhoeffer et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA Science 1998 279 2103 2106 1:CAS:528:DyaK1cXitFGksrg%3D 10.1126/science.279.5359.2103
8. C.M. Gray J. Lawrence J.M. Schapiro et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART) J. Immunol. 1999 162 1780 1788 1:CAS:528:DyaK1MXhtVWntrs%3D 9973442
9. S.A. Kalams P.J. Goulder A.K. Shea et al. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy J. Virol. 1999 73 6721 6728 1:CAS:528:DyaK1MXksFKnurw%3D 10400770 112757
10. W.B. Dyer G.S. Ogg M.-A. Demoitie et al. Strong human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1 J. Virol. 1999 73 436 443 1:CAS:528:DyaK1cXotFSksLg%3D 9847349 103850
11. C. Rinaldo X.L. Huang Z. Fan et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T lymphocytes activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors J. Virol. 1995 69 5838 5842 1:CAS:528:DyaK2MXns1Khs7c%3D 7637030 189455
12. M. Markowitz M. Vesanen K. Tenner-Racz et al. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses J. Infect. Dis. 1999 179 527 537 1:CAS:528:DyaK1MXhvVKksb4%3D 10.1086/314628
13. P.A. Krogstad J.A. Zack Detection of Viral DNA by PCR 1995 Oxford Oxford Univ. Press
14. Y. Cao L. Qin L. Zhang J. Safrit D.D. Ho Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection N. Engl. J. Med. 1995 332 201 208 1:STN:280:DyaK2M7gslemug%3D%3D 10.1056/NEJM199501263320401
15. X. Jin C.G. Roberts D.F. Nixon et al. Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission J. Infect. Dis. 1998 178 1317 1326 1:STN:280:DyaK1cvltlCntQ%3D%3D 10.1086/314455
16. R.A. Koup J.T. Safrit Y. Cao et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome J. Virol. 1994 68 4650 4655 1:STN:280:DyaK2c3msl2huw%3D%3D 8207839 236393
17. A. Carmichael X. Jin P. Sissons L. Borysiewicz Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein Barr virus in late disease J. Exp. Med. 1993 177 249 256 1:CAS:528:DyaK3sXhtVShtrc%3D 10.1084/jem.177.2.249
18. X. Jin D.E. Bauer S.E. Tuttleton et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques J. Exp. Med. 1999 189 991 998 1:CAS:528:DyaK1MXhvVOit7o%3D 10.1084/jem.189.6.991
19. J.E. Schmitz M.J. Kuroda S. Santra et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes Science 1999 283 857 860 1:CAS:528:DyaK1MXhtFSgurg%3D 10.1126/science.283.5403.857
20. J.D. Altman P.A.H. Moss P.J.R. Goulder et al. Phenotypic analysis of antigen-specific T lymphocytes Science 1996 274 94 96 1:CAS:528:DyaK28XmtVyns7k%3D 10.1126/science.274.5284.94
21. L. Musey J. Hughes T. Schacker T. Shea L. Corey M.J. McElrath Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection N. Engl. J. Med. 1997 337 1267 1274 1:STN:280:DyaK2svnsFygtA%3D%3D 10.1056/NEJM199710303371803
22. K. Murali J.D. Altman M. Suresh et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection Immunity 1998 8 177 187 10.1016/S1074-7613(00)80470-7